Dr Rebecca Darlay
Professor Heather Cordell
Professor Ann Daly
Professor Chris Day
Dr Steven Masson
| Corrigendum to: 'A genetic risk score and diabetes predict development of alcohol-related cirrhosis in drinkers' [J Hepatol 2022 (76) 275–282] (Journal of Hepatology (2022) 76(2) (275–282), (S0168827821021115), (10.1016/j.jhep.2021.10.005)) | 2022 |
|
Dr Olivier Govaere
Dr Rebecca Darlay
Dr Julien Peltier
Dr Jeremy Palmer
Dr Massimo Younes
et al. | Macrophage Scavenger Receptor 1 mediates lipid-induced inflammation in non-alcoholic fatty liver disease | 2022 |
|
Dr Rebecca Darlay
Dr Steven Masson
Professor Chris Day
Professor Ann Daly
Professor Heather Cordell
| Genome-wide association study and meta-analysis on alcohol-related liver cirrhosis identifies novel genetic risk factors | 2021 |
|
Dr Steven Masson
Professor Ann Daly
Professor Heather Cordell
Professor Chris Day
| Obesity, Diabetes, Coffee, Tea, and Cannabis Use Alter Risk for Alcohol-Related Cirrhosis in 2 Large Cohorts of High-Risk Drinkers | 2021 |
|
Professor Quentin Anstee
Dr Rebecca Darlay
Dr Simon Cockell
Dr Olivier Govaere
Dr Dina Tiniakos
et al. | Genome-Wide Association Study of Non-Alcoholic Fatty Liver and Steatohepatitis in a Histologically-Characterised Cohort | 2020 |
|
Dr Timothy Hardy
Kristy Wonders
Dr Massimo Younes
Professor Pierre Bedossa
Entesar Betelmal
et al. | The European NAFLD Registry: a real-world longitudinal cohort study of nonalcoholic fatty liver disease | 2020 |
|
Dr Olivier Govaere
Dr Simon Cockell
Dr Dina Tiniakos
Dr Rachel Queen
Dr Massimo Younes
et al. | Transcriptomic profiling across the nonalcoholic fatty liver disease spectrum reveals gene signatures for steatohepatitis and fibrosis | 2020 |
|
Professor Chris Day
Professor Alastair Burt
| Systems Genetics of Hepatic Metabolome Reveals Octopamine as a Target for Non-Alcoholic Fatty Liver Disease Treatment | 2019 |
|
Dr Dave Houghton
Dr Kate Hallsworth
Dr Sophie Cassidy
Christian Thoma
Dr Leah Avery
et al. | The degree of hepatic steatosis associates with impaired cardiac and autonomic function | 2019 |
|
Dr Steven Masson
Professor Ann Daly
Professor Heather Cordell
Professor Chris Day
| Evaluation of laboratory tests for cirrhosis and for alcohol use, in the context of alcoholic cirrhosis | 2018 |
|
Professor Quentin Anstee
Professor Chris Day
Professor Arun Sanyal
| Modeling NAFLD Disease Burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016-2030 | 2018 |
|
Dr Dave Houghton
Dr Timothy Hardy
Professor Christopher Stewart
Linda Errington
Professor Chris Day
et al. | Systematic review assessing the effectiveness of dietary intervention on gut microbiota in adults with type 2 diabetes | 2018 |
|
Professor Stuart McPherson
Dr Nina Wilson
Dr Dina Tiniakos
Dr Jennifer Wilkinson
Professor Alastair Burt
et al. | A randomised controlled trial of losartan as an anti-fibrotic agent in non-alcoholic steatohepatitis | 2017 |
|
Professor Stuart McPherson
Dr Timothy Hardy
Dr Dina Tiniakos
Professor Alastair Burt
Professor Chris Day
et al. | Age as a Confounding Factor for the Accurate Non-Invasive Diagnosis of Advanced NAFLD Fibrosis | 2017 |
|
Dr Sally Coulthard
Professor Chris Day
Professor Ann Daly
| Association of Liver Injury From Specific Drugs, or Groups of Drugs, With Polymorphisms in HLA and Other Genes in a Genome-Wide Association Study | 2017 |
|
